Cargando…

B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY

Detalles Bibliográficos
Autores principales: Rodriguez-Otero, P, Dholaria, B, Askari, E, Reece, D, van de Donk, N, Chari, A, Goldschmidt, H, Krishnan, A, Martin, T, Mateos, M, Morillo, D, Rodriguez, C, Rosinol, L, San-Miguel, J, Balari, A, Wäsch, R, Weisel, K, Verona, R, Lin, S, Prior, T, Wade, M, Weiss, B, Goldberg, J, Oriol, A, Hari, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012126/
http://dx.doi.org/10.1097/01.HS9.0000829556.56345.01
_version_ 1784687736863588352
author Rodriguez-Otero, P
Dholaria, B
Askari, E
Reece, D
van de Donk, N
Chari, A
Goldschmidt, H
Krishnan, A
Martin, T
Mateos, M
Morillo, D
Rodriguez, C
Rosinol, L
San-Miguel, J
Balari, A
Wäsch, R
Weisel, K
Verona, R
Lin, S
Prior, T
Wade, M
Weiss, B
Goldberg, J
Oriol, A
Hari, P
author_facet Rodriguez-Otero, P
Dholaria, B
Askari, E
Reece, D
van de Donk, N
Chari, A
Goldschmidt, H
Krishnan, A
Martin, T
Mateos, M
Morillo, D
Rodriguez, C
Rosinol, L
San-Miguel, J
Balari, A
Wäsch, R
Weisel, K
Verona, R
Lin, S
Prior, T
Wade, M
Weiss, B
Goldberg, J
Oriol, A
Hari, P
author_sort Rodriguez-Otero, P
collection PubMed
description
format Online
Article
Text
id pubmed-9012126
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-90121262022-04-18 B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY Rodriguez-Otero, P Dholaria, B Askari, E Reece, D van de Donk, N Chari, A Goldschmidt, H Krishnan, A Martin, T Mateos, M Morillo, D Rodriguez, C Rosinol, L San-Miguel, J Balari, A Wäsch, R Weisel, K Verona, R Lin, S Prior, T Wade, M Weiss, B Goldberg, J Oriol, A Hari, P Hemasphere Best Abstracts - Oral Presentations Lippincott Williams & Wilkins 2022-04-05 /pmc/articles/PMC9012126/ http://dx.doi.org/10.1097/01.HS9.0000829556.56345.01 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Best Abstracts - Oral Presentations
Rodriguez-Otero, P
Dholaria, B
Askari, E
Reece, D
van de Donk, N
Chari, A
Goldschmidt, H
Krishnan, A
Martin, T
Mateos, M
Morillo, D
Rodriguez, C
Rosinol, L
San-Miguel, J
Balari, A
Wäsch, R
Weisel, K
Verona, R
Lin, S
Prior, T
Wade, M
Weiss, B
Goldberg, J
Oriol, A
Hari, P
B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY
title B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY
title_full B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY
title_fullStr B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY
title_full_unstemmed B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY
title_short B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY
title_sort b04: combination of subcutaneous teclistamab with daratumumab in patients with relapsed/refractory multiple myeloma (rrmm): results from a phase 1b multicohort study
topic Best Abstracts - Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012126/
http://dx.doi.org/10.1097/01.HS9.0000829556.56345.01
work_keys_str_mv AT rodriguezoterop b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT dholariab b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT askarie b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT reeced b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT vandedonkn b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT charia b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT goldschmidth b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT krishnana b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT martint b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT mateosm b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT morillod b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT rodriguezc b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT rosinoll b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT sanmiguelj b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT balaria b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT waschr b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT weiselk b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT veronar b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT lins b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT priort b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT wadem b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT weissb b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT goldbergj b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT oriola b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy
AT harip b04combinationofsubcutaneousteclistamabwithdaratumumabinpatientswithrelapsedrefractorymultiplemyelomarrmmresultsfromaphase1bmulticohortstudy